Press Release – Cannasouth NZX listed medicinal cannabis company Cannasouth expects to be ready to export pharmaceutical grade cannabis flower in early 2022 after completing commissioning of its Waikato-based growing facility. Cannasouths joint venture partner, Cannasouth Cultivation Limited, … NZX listed medicinal cannabis company Cannasouth expects to be ready to export pharmaceutical grade cannabis flower in early 2022 after completing commissioning of its Waikato-based growing facility. Cannasouth’s joint venture partner, Cannasouth Cultivation Limited, which has developed a next generation controlled environment agriculture (CEA) sealed greenhouse has its first commercial harvest expected in December 2021. At the company’s AGM today, Cannasouth Chief Executive Mark Lucas told investors the facility will produce up to 1,800kg of pharmaceutical grade cannabis flower each year with the ability to scale the facility by four times as demand requires.